OLANZAPINE LONG-ACTING IM: 13 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
13
Total FAERS Reports
1 (7.7%)
Deaths Reported
10
Hospitalizations
13
As Primary/Secondary Suspect
First Report: 20121105 · Latest Report: 20140403
What Are the Most Common OLANZAPINE LONG-ACTING IM Side Effects?
#1 Most Reported
Sedation
9 reports (69.2%)
#2 Most Reported
Confusional state
5 reports (38.5%)
#3 Most Reported
Dizziness
4 reports (30.8%)
All OLANZAPINE LONG-ACTING IM Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Sedation | 9 | 69.2% | 0 | 7 |
| Confusional state | 5 | 38.5% | 0 | 5 |
Who Reports OLANZAPINE LONG-ACTING IM Side Effects? Age & Gender Data
Average age: 60.7 years. Most reports from: US. View detailed demographics →
Is OLANZAPINE LONG-ACTING IM Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 1 | 0 | 0 |
| 2013 | 7 | 1 | 6 |
| 2014 | 5 | 0 | 4 |
What Is OLANZAPINE LONG-ACTING IM Used For?
| Indication | Reports |
|---|---|
| Schizophrenia | 11 |
Official FDA Label for OLANZAPINE LONG-ACTING IM
Official prescribing information from the FDA-approved drug label.